Volume 60 • 1999 • Supplement 19

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Introduction. Antipsychotic Agents: Clinical, Economic, and Legal Considerations in the Treatment of Psychosis. [Free]

J Clin Psychiatry 1999;60(suppl 19):3-4

Use Patterns for Antipsychotic Medications in Medicaid Patients With Schizophrenia

J Clin Psychiatry 1999;60(suppl 19):5-11

Annual Health Outcomes and Treatment Costs for Schizophrenia Populations

J Clin Psychiatry 1999;60(suppl 19):14-19

Compliance and the Rehabilitation Alliance

J Clin Psychiatry 1999;60(suppl 19):23-27

Developing an Outcomes-Oriented Approach for the Treatment of Schizophrenia

J Clin Psychiatry 1999;60(suppl 19):30-35

Changes in Perceived Health and Functioning as a Cost-Effectiveness Measure for Olanzapine Versus Haloperidol Treatment of Schizophrenia

J Clin Psychiatry 1999;60(suppl 19):38-45

Effectiveness of Combining Atypical Antipsychotics and Psychosocial Rehabilitation in a Community Mental Health Center Setting

J Clin Psychiatry 1999;60(suppl 19):47-51

The Role of Neuropsychiatric Pharmacists

J Clin Psychiatry 1999;60(suppl 19):54-57

Legal and Ethical Considerations in the Treatment of Psychosis

J Clin Psychiatry 1999;60(suppl 19):59-65